Marcel Speek

Statistics

Publications

Citations

148

H-Index

Active since

2014

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Francis Hospital

McMaster University

Medizinische Hochschule Hannover

Thrombosis and Atherosclerosis Research Institute

Marcel Speek is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in sugammadex reversal, medicine, and surgical adverse event reporting.

Publications per year

2014–2021

Publications

Effect of Reversal of Neuromuscular Blockade with Sugammadex versus Usual Care on Bleeding Risk in a Randomized Study of Surgical Patients

Niels Rahe‐Meyer, Hein Fennema, Sam Schulman et al. · Anesthesiology · 2014 · 75 citations · Full text

Medicine, Orthopaedic Surgery, Surgery +17

Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: a randomized clinical trial

Jay Horrow, Wen Li, Manfred Blobner et al. · BMC Anesthesiology · 2021 · 32 citations · Full text

Medicine, Perioperative Medicine, Pharmacotherapy +17

Sugammadex for reversal of neuromuscular blockade in pediatric patients: Results from a phase IV randomized study

Tiffini Voss, Aobo Wang, Matthew DeAngelis et al. · Pediatric Anesthesia · 2021 · 25 citations

Medicine, Pediatrics, Pharmacotherapy +14

Effect of Reversal of Neuromuscular Blockade With Sugammadex Versus Usual Care on Bleeding Risk in a Randomized Study of Surgical Patients

Niels Rahe‐Meyer, Hein Fennema, Sam Schulman et al. · Survey of Anesthesiology · 2015 · 16 citations

Medicine, Orthopaedic Surgery, Surgery +17

1–4 of 4